FI

Falcon III Ventures

North America, Massachusetts, United States, Boston

Description

Falcon III Ventures Boston-based biotech Venture capital.

Investor Profile

Falcon III Ventures has made 2 investments, with 0 in the past 12 months and 100% as lead.

Stage Focus

  • Seed (50%)
  • Series Unknown (50%)

Country Focus

  • United States (50%)
  • Switzerland (50%)

Industry Focus

  • Artificial Intelligence (Ai)
  • Bioinformatics
  • Biotechnology
  • Machine Learning
  • Genetics
  • Health Care
  • Software
  • Biopharma
  • Information Technology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Falcon III Ventures frequently co-invest with?

SpringTide Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Aargauische Kantonalbank
Europe, Aargau, Switzerland, Aarau
Co-Investments: 1
BA
Europe, Aargau, Switzerland, Brugg
Co-Investments: 1
Verve Ventures
Europe, Zug, Switzerland, Zug
Co-Investments: 1
BB
Europe, Zug, Switzerland, Zug
Co-Investments: 1
Hyperplane
North America, Massachusetts, United States, Boston
Co-Investments: 1
Everywhere Ventures (The Fund)
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by Falcon III Ventures?

Biotia

Brooklyn, New York, United States

Biotia is a health tech startup offering AI-based solutions to diagnose and control infectious disease.

Artificial Intelligence (AI)BioinformaticsBiotechnologyGeneticsHealth CareMachine LearningSoftware
SeedDec 10, 2019
Amount Raised: $2,400,000
InterAx Biotech Ltd

Villigen, Aargau, Switzerland

Connecting biology, mathematical modelling and AI to accelerate drug discovery.

Artificial Intelligence (AI)BioinformaticsBiopharmaBiotechnologyInformation TechnologyMachine Learning
Series UnknownJan 15, 2019
Amount Raised: $3,038,550